Effects of tachykinin NK1 receptor antagonists on vagal hyperreactivity and neuronal M2 muscarinic receptor function in antigen challenged guinea-pigs

1. The role of tachykinin NK₁ receptors in the recruitment of eosinophils to airway nerves, loss of inhibitory neuronal M₂ muscarinic receptor function and the development of vagal hyperreactivity was tested in antigen-challenged guinea-pigs.
2. In anaesthetized guinea-pigs, the muscarinic agonist, pilocarpine (1–100 μg kg⁻¹, i.v), inhibited vagally induced bronchoconstriction, in control, but not in antigen-challenged guinea-pigs 24 h after antigen challenge. This indicates normal function of neuronal M₂ muscarinic receptors in controls and loss of neuronal M₂ receptor function in challenged guinea-pigs. Pretreatment of sensitized guinea-pigs with the NK₁ receptor antagonists CP99994 (4 mg kg⁻¹, i.p.), SR140333 (1 mg kg⁻¹, s.c.) or CP96345 (15 mg kg⁻¹, i.p.) before antigen challenge, prevented M₂ receptor dysfunction.
3. Neither administration of the NK₁ antagonists after antigen challenge, nor pretreatment with an NK₂ receptor antagonist, MEN10376 (5 μmol kg⁻¹, i.p.), before antigen challenge, prevented M₂ receptor dysfunction.
4. Electrical stimulation of the vagus nerves caused a frequency-dependent (2–15 Hz, 10 V, 0.2 ms for 5 s) bronchoconstriction that was significantly increased following antigen challenge. Pretreatment with the NK₁ receptor antagonists CP99994 or SR140333 before challenge prevented this increase.
5. Histamine (1–20 nmol kg⁻¹, i.v.) caused a dose-dependent bronchoconstriction, which was vagally mediated, and was significantly increased in antigen challenged guinea-pigs compared to controls. Pretreatment of sensitized animals with CP99994 before challenge prevented the increase in histamine-induced reactivity.
6. Bronchoalveolar lavage and histological studies showed that after antigen challenge significant numbers of eosinophils accumulated in the airways and around airway nerves. This eosinophilia was not altered by pretreatment with the NK₁ receptor antagonist CP99994.
7. These data indicate that pretreatment of antigen-sensitized guinea-pigs with NK₁, but not with NK₂ receptor antagonists before antigen challenge prevented the development of hyperreactivity by protecting neuronal M₂ receptor function. NK₁ receptor antagonists do not inhibit eosinophil accumulation around airway nerves.